Highbridge Capital Management »

Esperion Therapeutics shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $663M 222k 2990.00
2023-09-30 $249k 254k 0.98
2023-06-30 $353k 254k 1.39
2023-03-31 $404k 254k 1.59
2022-12-31 $1.6M 254k 6.23
2022-06-30 $2.7M 420k 6.36
2022-03-31 $1.9M 420k 4.64
2021-12-31 $1.7M 346k 5.00
2017-03-31 $1.1M 31k 35.31
2016-09-30 $165k 12k 13.78
2015-09-30 $5.6M 237k 23.59
2015-03-31 $8.8M 95k 92.61